Exelixis Reveals Preliminary Financial Outcomes for 2024 and Sets Ambitious Goals for 2025
January 13, 2025 - 02:56
ALAMEDA, Calif., January 12, 2025—Exelixis, Inc. has announced its preliminary unaudited financial results for the fiscal year 2024, alongside financial guidance for the upcoming fiscal year 2025. The company is optimistic about the potential for significant advancements in clinical and regulatory efforts, particularly concerning its cabozantinib franchise.
In 2025, Exelixis plans to focus on executing its clinical programs and anticipates multiple data readouts for zanzalintinib, as well as developments across its diverse pipeline of small molecules and biotherapeutics. The company aims to leverage its existing assets while exploring new opportunities to enhance its market position.
With a clear strategy in place, Exelixis is poised for a year of growth, innovation, and impactful milestones that could shape the future of its therapeutic offerings. The commitment to advancing patient care remains at the forefront of Exelixis's mission as it navigates the challenges and opportunities ahead.
MORE NEWS
April 10, 2026 - 17:48
March's sticky inflation may be the proof Fed needs to hold ratesThe latest inflation snapshot from March has provided Federal Reserve officials with fresh evidence that price pressures remain persistent, strengthening the argument to maintain the current...
April 10, 2026 - 01:10
TSX Penny Stocks To Watch In April 2026As markets find firmer footing this April, investor attention is turning toward potential growth opportunities. Following a volatile March, the S&P 500 and the S&P/TSX Composite Index have both...
April 9, 2026 - 03:34
Fed's March minutes: Officials saw Iran war increasing inflation, delaying rate cutsMinutes from the Federal Reserve`s March policy meeting reveal a heightened concern among officials that escalating geopolitical tensions could complicate the fight against inflation. Specifically,...
April 8, 2026 - 03:06
Stock market today: S&P 500, Nasdaq close slightly higher on hopes of Iran deadline extensionFinancial markets breathed a cautious sigh of relief on Wednesday, with major indices closing slightly higher as investors clung to hopes for a diplomatic extension on a critical deadline...